Maximum Dose of Sodium Zirconium Cyclosilicate (Lokelma)
The maximum recommended dose of sodium zirconium cyclosilicate is 15 g once daily for maintenance therapy. 1
Dosing Algorithm
Initial Treatment Phase (Acute Hyperkalemia)
- Standard dose: 10 g three times daily (TID) for up to 48 hours 1
- Total daily maximum during correction: 30 g/day (10 g × 3 doses)
- This regimen rapidly lowers potassium, with normalization typically occurring within 2.2 hours (median) and 98% of patients achieving normokalemia by 48 hours 2
Maintenance Treatment Phase
- Starting dose: 10 g once daily 1
- Dose range: 5 g every other day to 15 g once daily 1
- Maximum maintenance dose: 15 g once daily 2
- Titrate in 5 g increments at intervals of 1 week or longer based on serum potassium levels 1
Special Population: Chronic Hemodialysis
- Starting dose: 5 g once daily on non-dialysis days 1
- For severe hyperkalemia (K+ >6.5 mEq/L): Consider 10 g once daily on non-dialysis days 1
- Maximum: 15 g once daily on non-dialysis days 1
Clinical Evidence Supporting Dosing
The HARMONIZE and HARMONIZE-OLE trials established the efficacy of the 15 g maximum dose 2. In HARMONIZE, patients receiving 15 g once daily maintained mean serum potassium of 4.4 mEq/L during days 8-29, with 94% achieving normokalemia 2. The 12-month HARMONIZE-OLE study confirmed that doses were titrated between 5-15 g daily to maintain target potassium levels, with 93% of patients achieving mean serum potassium ≤5.1 mEq/L 2.
Important Safety Considerations
Edema risk increases with higher doses, particularly at 15 g daily 2. In clinical trials, edema incidence was 14% in the 15 g group compared to 2% with placebo 2. Each 5 g dose contains approximately 400 mg of sodium, meaning the maximum 15 g daily dose delivers ~1200 mg sodium 1. Monitor patients prone to fluid overload (heart failure, renal disease) more closely when using higher doses.
Hypokalemia risk: In maintenance trials, 11% of patients receiving 15 g developed hypokalemia (K+ <3.5 mEq/L) 3. Monitor serum potassium weekly after dose adjustments and discontinue or reduce dose if potassium falls below target range 1.
Common Pitfalls to Avoid
- Do not exceed 15 g once daily during maintenance - no evidence supports higher doses and adverse events increase dose-dependently 1
- Do not use as emergency treatment - onset of action is 1 hour, making it unsuitable for life-threatening hyperkalemia requiring immediate intervention 1
- Separate from other oral medications by 2 hours - SZC can bind other drugs in the GI tract 1
- Do not use correction phase dosing (10 g TID) beyond 48 hours - transition to once-daily maintenance dosing 1